✦ LIBER ✦

O-098 Survival equivalence of non-platinum-based and platinum-basedchemotherapy for advanced non-small cell lung cancer (NSCLC): The results of a multicenter internet-based Phase III randomized study (D0112)

✍ Scribed by Rigas, J.; Dragnev, K.; Kerry, M.; Cole, B.; Evans, A.; Page, R.; Yunus, F.; Rubin, M.; Ghazal, H.; Maher, J.

Book ID: 118572646
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 131 KB
Volume: 49
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(05)80232-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Should chemotherapy combinations for adv

Should chemotherapy combinations for advanced non-small cell lung cancer be platinum-based? A meta-analysis of phase III randomized trials

✍ Pujol, Jean-Louis; Barlesi, Fabrice; Daurès, Jean-Pierre 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 163 KB

P-204 Mature results of a non-platinum-b

P-204 Mature results of a non-platinum-based [gemcitabine and paclitaxel (GEMPAC)] phase II study in patients (Pts) with advanced non-small cell lung cancer (NSCLC)

✍ Wozniak, Antoinette J. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 388 KB

PD-079 Should chemotherapy combinations

PD-079 Should chemotherapy combinations for advanced non-small cell lung cancer (NSCLC) be platinum-based? A literature-based meta-analysis of phase III randomised trials

✍ Pujol, J.; Barlesi, F.; Daures, J. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Platinum-based combination chemotherapy

Platinum-based combination chemotherapy in advanced non-small cell lung cancer: A randomized phase II trial of the cancer and leukemia group B

✍ Green, Mark R. ;Kramar, Andrew ;Schilsky, Richard ;Stoopler, Marc ;Zimmer, Bonni 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 504 KB

## Abstract The Cancer and Leukemia Group B (CALGB) utilized a randomized phase II trial design to evaluate two cisplatin‐based combinations, cisplatin‐cytarabine (ara‐C) and cisplatin‐vinblastine, in 151 patients with advanced non‐small cell lung cancer. Patients entered on study had not received

O-083 A multicenter phase IIB randomized

O-083 A multicenter phase IIB randomized study of the liposomal MUC1 vaccine L-BLP25 for immunotherapy of advanced non-small cell lung cancer (NSCLC)

✍ Butts, C. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 130 KB

Vinflunine – an active chemotherapy for

Vinflunine – an active chemotherapy for treatment of advanced non-small-cell lung cancer previously treated with a platinum-based regimen: results of a phase II study

✍ Bennouna, J; Breton, J-L; Tourani, J-M; Ottensmeier, C; O'Brien, M; Kosmidis, P; 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 118 KB